Back to mobile site

Amgen (AMGN) PT Lowered to $250 at Jefferies

November 3, 2021 8:03 AM EDT Send to a Friend
Jefferies analyst Michael Yee lowered the price target on Amgen (NASDAQ: AMGN) to $250.00 (from $270.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login